Media

Last week, Congresswoman Sydney Kamlager-Dove (CA-37) joined Democratic Women’s Caucus (DWC) White House Liaison Rep. Joyce Beatty (OH-03), Chair Lois Frankel (FL-22), and Vice Chairs Nikema Williams (GA-05) and Teresa Leger Fernández (NM-03) in urging the Biden-Harris Administration to protect Americans from the criminalization of their pregnancies and pregnancy outcomes in the wake of Dobbs v. Jackson Women’s Health Organization. 

I am wishing everyone across CA-37 a Happy Black History Month! Black History is alive and present across Los Angeles.

While we continue to combat climate change and build climate resiliency, I welcome the Department of Energy’s (DOE) decision to halt LNG exports.

I voted against H.R. 7024, the Tax Relief for American Families and Workers Act. As someone who has built a legacy fighting against injustice and advocating for equitable opportunities for Angeleno children and families, this legislation falls remarkably short.

WASHINGTON, DC - Today, Congresswoman Sydney Kamlager-Dove (CA-37) joined Congresswoman Ayanna Pressley (MA-07), Co-Founder and Co-Chair of the Congressional Caucus for the Equal Rights Amendment, ERA Caucus Co-Chair Congresswoman Cori Bush (MO-01), and Representatives Madeleine Dean (PA-04), Sylvia Garcia (TX-29), and Abigail Spanberger (VA-07) in releasing a statement marking the one-year anniversary of the introduction of H.J. Res. 25, a resolution to affirm the ratification of the Equal Rights Amendment (ERA) and enshrine it as the 28th Amendment.

Yesterday, 263 Members of Congress—led by U.S. Senators Schumer, Murray, Sanders, Durbin, and Blumenthal and Representatives Jeffries, Clark, Pallone, Nadler, DeGette, and Lee—submitted an amicus brief to the U.S. Supreme Court in the case of Alliance for Hippocratic Medicine v. FDA, urging the Supreme Court to reverse a stay from Texas District Court Judge Matthew Kacsmaryk, reaffirmed in part by the U.S. Court of Appeals for the Fifth Circuit, that would override the Food and Drug Administration (FDA)’s scientific judgment and dramatically curtail access to mifepristone—a safe and effective medication abortion drug that was approved by the FDA in 2000 and is used in more than half of all abortions in the U.S. At issue in the case are evidence-based regulatory actions the FDA took in 2016 and 2021 that broadened access to mifepristone, including extending the time frame for mifepristone use during the early stages of pregnancy and removing onerous in-person dispensing requirements for mifepristone. 

Putting an end to the Biden-Harris Administration’s Cuba, Haiti, Nicaragua, and Venezuela (CHNV) parole program or severely restricting the President’s parole authority would exacerbate challenges at our Southern border and deal a cruel blow to migrants who depend on this vital lifeline for survival.

The 37th Congressional District is home to a vibrant African diaspora, and I was glad to host this event to engage with the Ethiopian community and bring to life my work on the House Foreign Affairs Subcommittee on Africa.